Aardvark Therapeutics, INC. (AARD) — 10-K Filings
All 10-K filings from Aardvark Therapeutics, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Aardvark Pauses Key Trials Amid Cardiac Safety Concerns
— Mar 23, 2026 Risk: high
Aardvark Therapeutics, Inc. (AARD) is a clinical-stage biopharmaceutical company focused on developing novel small-molecule therapeutics for metabolic diseases. - 10-K Filing — Mar 31, 2025
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX